Association of hepatitis B virus mutations of A1846T and C1913A/G with acute-on-chronic liver failure development from different underlying chronic liver diseases

Hepatitis Monthly

Volumn 13, Issue 9, 2013, Pages

  Zhang, Aimin ^a   Wan, Zhihong ^a   You, Shaoli ^a   Liu, Hongling ^a   Zhu, Bing ^a   Chen, Jing ^a   Rong, Yihui ^a   Zang, Hong ^a   Li, Chen ^a   Wang, Huifen ^a   Xin, Shaojie ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Hepatitis B Virus; Liver failure; Mutation; Risk factors

Indexed keywords

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; RISK FACTOR; VIRUS MUTANT; VIRUS MUTATION;

EID: 84884686252     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.12445     Document Type: Article

References (31)

1. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3(1):269-82.
2. [Diagnostic and treatment guidelines for liver failure]. Zhonghua Gan Zang Bing Za Zhi. 2006;14(9):643-6.
3. You Shaoli, Rong Yihui, Zhu Bing, Zhang Aimin, Zang Hong, Liu Hongling, et al. Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol Int. 2013;7(2):714-720.
4. Kao* Jia-Horng, Chen* Pei-Jer, Lai* Ming-Yang, Chen‡ § Ding-Shinn. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118(3):554-559.
5. Malik A, Singhal DK, Albanyan A, Husain SA, Kar P. Hepatitis B virus gene mutations in liver diseases: a report from New Delhi. PLoS One. 2012;7(6).
6. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991;324(24):1699-704.
7. Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang JH, Hige S, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44(2):326-34.
8. Chauhan R, Kazim SN, Bhattacharjee J, Sakhuja P, Sarin SK. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol. 2006;78(8):1047-54.
9. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol. 2008;89(Pt 4):901-9.
10. Ren X, Xu Z, Liu Y, Li X, Bai S, Ding N, et al. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat. 2010;17(12):887-95.
11. Xiao L, Zhou B, Gao H, Ma S, Yang G, Xu M, et al. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure. J Med Virol. 2011;83(9):1544-50.
12. Xu Z, Ren X, Liu Y, Li X, Bai S, Zhong Y, et al. Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-onchronic liver failure. J Gastroenterol. 2011;46(3):391-400.
13. Liu XH, Zheng SJ, Zu KJ, Chen Y, Chen YS, Wang TL, et al. [A retrospective study of clinical and pathological spectrum in 91 patients with chronic severe hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2010;18(10):721-5.
14. Zeng Z, Lou M, Han YK, Geng H, Chang XJ, Chen JM. [To re-evaluate the clinical classification criteria of liver failure]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007;21(4):377-9.
15. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, et al. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc. 2005;37(10):4359-64.
16. Wai CT, Lim SG, Aung MO, Lee YM, Sutedja DS, Dan YY, et al. MARS: a futile tool in centres without active liver transplant support. Liver Int. 2007;27(1):69-75.
17. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, Chen QY, et al. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol. 2008;103(9):2254-62.
18. Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, et al. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol. 2011;106(1):81-92.
19. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method. J Infect Dis. 1997;175(6):1285-93.
20. Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29(3):976-84.
21. Chen CH, Lee CM, Lu SN, Changchien CS, Eng HL, Huang CM, et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol. 2005;43(12):6000-6.
22. Sugauchi F, Orito E, Ohno T, Tanaka Y, Ozasa A, Kang JH, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res. 2006;36(2):107-14.
23. Chu CM, Lin CC, Chen YC, Jeng WJ, Lin SM, Liaw YF. Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection. Br J Cancer. 2012;107(12):2010-5.
24. Zhang AM, Wang HF, Wang HB, Hu JH, He WP, Su HB, et al. [Association between HBV genotype and chronic/severe liver disease with HBV infection in Chinese patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010;24(3):178-80.
25. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100(16):1134-43.
26. Yuen MF, Tanaka Y, Mizokami M, Yuen JC, Wong DK, Yuan HJ, et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis. 2004;25(9):1593-8.
27. Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A. 1994;91(9):4077-81.
28. Yan T, Li K, Li F, Su H, Mu J, Tong S, et al. T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C. J Med Virol. 2011;83(6):996-1004.
29. Chain BM, Myers R. Variability and conservation in hepatitis B virus core protein. BMC Microbiol. 2005;5:33.
30. Radecke Klaus, Protzer Ulrike, Trippler Martin, Meyer zum Büschenfelde Karl-Herrmann, Gerken Guido. Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-α therapy. J Med Virol. 2000;62(4):479-486.
31. Torre F, Cramp M, Owsianka A, Dornan E, Marsden H, Carman W, et al. Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity. J Med Virol. 2004;72(3):370-6.